• Rimonabant (SR141716) Assay Guide

  2026-09-15

  This scenario-based guide explains how Rimonabant (SR141716), SKU B1429, can improve mechanistic interpretation in CB1-linked viability, cytotoxicity, and endocannabinoid research. It covers solvent compatibility, dose translation, data interpretation, and practical supplier-selection criteria.

• NF 449 for P2X1 Platelet Studies

  2026-09-15

  NF 449 is a high-potency purinergic receptor antagonist for separating ATP-driven P2X1 signaling from broader platelet responses. This guide translates receptor pharmacology into practical calcium-flux, aggregation, and thrombosis workflows with dose-selection and troubleshooting strategies.

• Shenqi Fuzheng Injection in Glioma: SRC/PI3K/AKT

  2026-09-14

  This study combines network pharmacology with cell-based and mouse experiments to investigate how Shenqi Fuzheng injection affects glioma proliferation and migration. Its main contribution is linking predicted SFI targets to experimental evidence implicating SRC/PI3K/AKT signaling, while also identifying important limits for translating pathway-level findings into anti-angiogenic or receptor-directed research.

• SARS-CoV-2 N Protein, GADD34, and Atypical Foci

  2026-09-14

  The reference study identifies a mechanism in which SARS-CoV-2 nucleocapsid protein redirects GADD34 mRNA into atypical G3BP1-positive foci, limiting GADD34 expression and downstream IRF3 activity. Its findings connect stress-granule biology with innate immune evasion and suggest experimental strategies for separating RNA localization, protein interaction, and interferon signaling effects.

• AGO1, Protein Folding, and Stem Cell Fate

  2026-09-13

  The 2024 Developmental Cell study identifies an RNA-independent role for AGO1 in maintaining mouse embryonic stem cell self-renewal. It shows that AGO1 engages the HOP chaperone cofactor to support folding of selected intrinsically disordered proteins, distinguishing AGO1 from AGO2 and expanding the functional scope of Argonaute biology.

• tFUS, SHP2, and Neuroinflammation After Stroke

  2026-09-12

  A 2025 study links low-intensity transcranial focused ultrasound stimulation with suppression of post-stroke NLRP3 neuroinflammation through the Nespas/miR-383-3p/SHP2 axis. Its combination of a transient MCAO model, microglial OGD/R experiments, RNA sequencing, and targeted perturbation provides a mechanistic framework for studying SHP2 in ischemic brain injury.

• PEP, cGAS–STING, and Healthy Aging

  2026-09-12

  A 2026 Nature Aging study identifies phosphoenolpyruvate (PEP) as an endogenous metabolic brake on cGAS–STING-driven inflammation. Longitudinal, mechanistic, and disease-model experiments suggest that preserving physiological PEP availability may help limit inflammaging and neuroinflammation, although human intervention remains unestablished.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-09-11

  This 2024 Nature Communications study identifies SmD2 acetylation as a regulatory link between core spliceosome activity, BRCA1/FANC cassette-exon processing, and PARP inhibitor response in hepatocellular carcinoma. Its preclinical data support combining HDAC2-directed spliceosome regulation with PARP inhibition, while also defining important questions for biomarker-guided cancer research.

• Iron Stress Reprograms Enterocyte Metabolism

  2026-09-11

  Navazesh and Ji used paired iron-deficiency and iron-excess perturbations in IPEC-J2 enterocytes to show that iron imbalance produces distinct transcriptional, inflammatory, and metabolic states. The study links iron deficiency to impaired proliferation and glycolytic adaptation, while iron excess favors cholesterol synthesis and lowers alpha-tocopherol, with partial metabolic recovery after iron repletion.

• Acetylspiramycin Workflow for Resistance Studies

  2026-09-10

  Acetylspiramycin (Spiramycin B) provides a practical 50S-targeting comparator for macrolide-resistance experiments, especially when erythromycin and azithromycin no longer resolve susceptibility differences. This workflow combines solvent control, broth microdilution, molecular stratification, and cautious extension into immune modulation studies.

• Ceftazidime: Mechanism and Resistance Research

  2026-09-10

  Ceftazidime is a third-generation cephalosporin with important activity against aerobic Gram-negative bacteria, including Pseudomonas aeruginosa. Its research value is strongest when phenotypic susceptibility is interpreted alongside β-lactamase, plasmid, and transmission data.

• AG-126: ERK1/2 Assays in Striatal Models

  2026-09-09

  AG-126 (Tyrphostin AG-126) provides a practical pharmacology tool for testing ERK1/2 phosphorylation and cytokine-linked signaling in cellular assays. This guide connects established inflammatory-model evidence with a carefully bounded strategy for studying ERK pathway involvement in Neuroligin 1–D2-MSN research.

• Iron Stress Reprograms Enterocyte Metabolism

  2026-09-09

  Navazesh and Ji show that both iron deficiency and iron excess remodel metabolism and inflammatory gene expression in IPEC-J2 enterocytes, but through distinct patterns of transcriptional and metabolic change. The study’s combined iron perturbation, LPS challenge, and untargeted metabolomics design provides a useful framework for linking cellular iron status to intestinal proliferation, energy production, and epithelial resilience.

• FCCP Workflows for Mitochondrial Research

  2026-09-08

  Use FCCP to connect mitochondrial respiration, ATP production, hypoxia signaling, and organelle quality control in one experimentally controlled workflow. This guide pairs practical dosing and troubleshooting with the MARCH5–PEX3 findings that sharpen interpretation in mitochondrial biology research.

• BIBR 1532: A Translational Telomerase Strategy

  2026-09-07

  BIBR 1532 offers translational researchers a mechanistically distinct way to interrogate telomerase dependence, linking hTERT inhibition with telomere attrition, transcriptional control, cancer cell proliferation inhibition, and apoptosis. This article positions the compound alongside emerging telomere-damaging strategies and provides a practical framework for combining enzyme, molecular, and phenotypic readouts.

8411 records 1/561 page Next 12345 下5页 Last page